Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease

Syed, Imran; Martinez, Matthew W.; Feng, Da Li; Glockner, James F.

doi:10.1016/j.ijcard.2007.01.019

Cited by 80 publications

(66 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Also, this form of LV wall thickening can by discriminated from LV myocardial hypertrophy using LGE imaging, which reveals thickening of the endocardium and increased signal intensity, accompanied by LV cavity thrombus formation, indicated by black spots aligning the endocardium. 47 conclusions Within the last decade, a large body of research has demonstrated the diagnostic accuracy of CMR, and the development of new sequences and techniques holds promise for an increasing role of CMR in the diagnostic work-up and monitoring of nonischaemic cardiomyopathies. However, the majority of previous studies were single centre, and therefore its diagnostic accuracy in common practice is currently unknown.…”

Section: Endomyocardial Fibrosismentioning

confidence: 99%

The role of cardiac magnetic resonance imaging in differentiating the underlying causes of left ventricular hypertrophy

Germans

Nijveldt²,

Brouwer³

et al. 2010

NHJL

View full text Add to dashboard Cite

135reVIeW ArtIcle the role of cardiac magnetic resonance imaging in differentiating the underlying causes of left ventricular hypertrophyThe onset of sudden cardiac death and large inter-and intra-familial clinical variability of hyper trophic cardiomyopathy pose an important clinical challenge. Cardiac magnetic resonance imaging is a high-resolution imaging modality that has become increasingly available in the past decade and has the unique possibility to demonstrate the presence of fibrosis or scar using late gadolinium enhancement imaging. As a result, the diagnostic and prognostic potential of cardiac magnetic resonance imaging has been extensively explored in acute and chronic ischaemic cardiomyopathy, as well as in several nonischaemic cardiomyopathies.This review aims to provide a critical overview of recently published studies on hypertrophic cardiomyopathy and discusses the role of cardiac magnetic resonance imaging in differentiating underlying causes of hypertrophic cardiomyopathy, such as familial hypertrophic cardiomyopathy, cardiac involvement in systemic disease and left ventricular hypertrophy due to endurance sports. Also, it demonstrates the use of cardiac magnetic resonance in risk stratification for the onset of sudden cardiac death, and early identification of asymptomatic family members of hypertrophic cardiomyopathy patients who are at risk for the development of hypertrophic cardiomyopathy. (Neth Heart J 2010;18:135-43.)

show abstract

Section: Endomyocardial Fibrosismentioning

confidence: 99%

The role of cardiac magnetic resonance imaging in differentiating the underlying causes of left ventricular hypertrophy

Germans

Nijveldt²,

Brouwer³

et al. 2010

NHJL

View full text Add to dashboard Cite

show abstract

“…Nowadays CMR has emerged as a highly useful noninvasive modality for the diagnosis of cardiac involvement in HES. It has a higher accuracy for the detection of ventricular thrombi and delayed enhancement gadolinium imaging is capable of detecting myocardial fibrosis and inflammation [4]. Cardiac involvement is less common in lymphocytic than myeloproliferative variants.…”

Section: Discussionmentioning

confidence: 99%

Atypical cardiac manifestation of hypereosinophilic syndrome and reversible cardiotoxicity to imatinib

García‐Álvarez

Sitges

García-Albéniz

et al. 2010

International Journal of Cardiology

View full text Add to dashboard Cite

“…Debl et al [48] have suggested the potential for CMRI to evaluate response to treatment, with a decrease in the extent of late enhancement occurring with successful steroid therapy. Syed et al [46] has also described severe hypertrophy of the LV myocardium and partial obliteration of the LV cavity in systole.…”

Section: Cmri Appearancesmentioning

confidence: 97%

“…A two-or threelayered appearance post contrast is most commonly described, consisting of a normal appearing epicardium, a hyperintense subendocardium indicating eosinophilic infiltration and frequently a linear hypointense layer of thrombus in the endocardium (Figure 6) [46,47] . Histological evaluation has confirmed the presence of endomyocardial eosinophilic infiltration and areas of myocyte necrosis.…”

Section: Cmri Appearancesmentioning

confidence: 99%

Investigation of cardiomyopathy using cardiac magnetic resonance imaging part 2: Rare phenotypes

O’Neill

McDermott

Ridge³

et al. 2012

WJC

View full text Add to dashboard Cite

Cardiac magnetic resonance imaging (CMRI) has emerged as a useful tertiary imaging tool in the investigation of patients suspected of many different types of cardiomyopathies. CMRI images are now of a sufficiently robust quality to enable high spatial and temporal resolution image acquisition. This has led to CMRI becoming an effective non-invasive imaging tool for many cardiomyopathies. In this two-part review we outline the typical sequences used to image cardiomyopathy and present the imaging spectrum of cardiomyopathy. Part Ⅰ focused on the current classification of cardiomyopathy, the basic CMRI sequences used in evaluating cardiomyopathy and the imaging spectrum of common phenotypes. Part Ⅱ illustrates the imaging spectrum of the more rare phenotypes.

show abstract

Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease

Cited by 80 publications

References 8 publications

The role of cardiac magnetic resonance imaging in differentiating the underlying causes of left ventricular hypertrophy

The role of cardiac magnetic resonance imaging in differentiating the underlying causes of left ventricular hypertrophy

Atypical cardiac manifestation of hypereosinophilic syndrome and reversible cardiotoxicity to imatinib

Investigation of cardiomyopathy using cardiac magnetic resonance imaging part 2: Rare phenotypes

Contact Info

Product

Resources

About